Professor, Medicine, Case Western Reserve University School of Medicine
Cardiology
Dr. Mina K. Chung, MD
|
|
Give Review
Mina Chung works in the field of Cardiology. She went to medical school at Washington University School of Medicine in St. Louis. She has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Dr. Mina K. Chung is also published. She has 61 publications published. The lastest publication: "A prospective study of anxiety in ICD patients with a pilot randomized controlled trial of cognitive behavioral therapy for patients with moderate to severe anxiety.'
Publications
- A prospective study of anxiety in ICD patients with a pilot randomized controlled trial of cognitive behavioral therapy for patients with moderate to severe anxiety.
- Left Atrial Transcriptional Changes Associated with Atrial Fibrillation Susceptibility and Persistence.
- REPLACE DARE (Death After Replacement Evaluation) Score: Determinants of All-Cause Mortality After Implantable Device Replacement Or Upgrade from the REPLACE Registry.
- Global Left Atrial Strain in the Prediction of Sinus Rhythm Maintenance after Catheter Ablation for Atrial Fibrillation.
- An intergenic regulatory region mediates Drosophila Myc-induced apoptosis and blocks tissue hyperplasia.
- The Role of the Wearable Cardioverter Defibrillator in Clinical Practice.
- Is DeFibrillation Testing Necessary?
- HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not included or Not Well Represented in Clinica...
- Left Ventricular Hypertrophy and Antiarrhythmic Drugs in Atrial Fibrillation: Impact on Mortality.
- Novel Genetic Markers Associate with Atrial Fibrillation Risk in Europeans and Japanese.
- Atrial Fibrillation Associated Chromosome 4q25 Variants Are Not Associated with PITX2c Expression in Human Adult Left Atrial Appendages.
- Does CHA2DS2-VASc Improve Stroke Risk Stratification in Postmenopausal Women with Atrial Fibrillation?
- Normalization of left ventricular ejection fraction after cardiac resynchronization therapy also normalizes survival.
- Real-time ultrasound guidance reduces total and major vascular complications in patients undergoing Pulmonary vein antral isolation on therapeutic warfarin.
- Superior vena cava defibrillator coils make transvenous lead extraction more challenging and riskier.
- Perioperative Heart-type fatty acid binding protein levels in atrial fibrillation after cardiac surgery.
- QRS narrowing is associated with reverse remodeling in patients with Chronic right ventricular pacing upgraded to cardiac resynchronization therapy.
- Implantable cardioverter-defibrillator FDA safety advisories: Impact on patient mortality and morbidity.
- Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry.
- Influence of Race on Atrial Fibrillation after Cardiac Surgery.
- Prevalence of Anxiety and Type D Personality in an Outpatient ICD Clinic.
- The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the Perioperative Management of Patients with Implantable Defi...
- QRS Fragmentation Is Not Associated with Poor Response to Cardiac Resynchronization Therapy.
- A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with Atrial fibrillation.
- The QRS Narrowing Index Predicts Reverse Left Ventricular Remodeling Following Cardiac Resynchronization Therapy.
- Independent susceptibility markers for Atrial fibrillation on chromosome 4q25.
- Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural Heart disease.
- Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival.
- Effectiveness of implantable cardioverter-defibrillator lead coil treatments in facilitating ease of extraction.
- Left Atrial epicardial adiposity and Atrial fibrillation.
- Common variants in KCNN3 are associated with lone Atrial fibrillation.
- Genome-wide association study of PR interval.
- Omega-3 fatty acid supplementation for the prevention of Arrhythmias.
- Prognostic value of electrocardiographic measurements before and after cardiac resynchronization device implantation in patients with Heart failure due to ischemic or ...
- Atrial glutathione content, calcium current, and contractility.
- Effects of cocaine intoxication on the threshold for stun gun induction of ventricular Fibrillation.
- Residual high incidence of ventricular Arrhythmias after left ventricular reconstructive surgery.
- Reduced cardioversion thresholds for Atrial fibrillation and flutter using the rectilinear biphasic waveform.
- Effect of statin therapy on risk of ventricular arrhythmia among patients with Coronary artery disease and an implantable cardioverter-defibrillator.
- Pacing the right ventricle: to pace or not to pace?
- Strategies for stroke prevention in Atrial fibrillation.
- Relation of C-reactive protein correlates with risk of thromboembolism in patients with Atrial fibrillation.
- Comparison of the rectilinear biphasic waveform with the monophasic damped sine waveform for external cardioversion of Atrial fibrillation and flutter.
- Relation of an exaggerated rise in white blood cells after Coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively.
- Vitamins, supplements, herbal medicines, and Arrhythmias.
- Randomized trials of rate vs. rhythm control for Atrial fibrillation.
- Inflammation as a risk factor for Atrial fibrillation.
- QRS duration and prediction of mortality in patients undergoing risk stratification for ventricular Arrhythmias.
- Current clinical issues in Atrial fibrillation.
- Atrial fibrillation: rate control is as good as rhythm control for some, but not all.
- Proarrhythmic effects of post-operative pacing intended to prevent Atrial fibrillation: evidence from a clinical trial.
- Dietary Ï3 fatty acids modulate the substrate for post-operative Atrial fibrillation in a canine cardiac surgery model.
- Functional status in rate- versus rhythm-control strategies for Atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (A...
- Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry.
- Mechanisms by which SCN5A mutation N1325S causes cardiac Arrhythmias and sudden death in vivo.
- New hope for the prevention of recurrent Atrial fibrillation.
- Do electrical stun guns (TASER-X26) affect the functional integrity of implantable pacemakers and defibrillators?
- Therapy Insight: interactions between Atrial fibrillation and obstructive sleep apnea.
- Atrial fibrillation, sleep apnea and obesity.
- Successful spouse pregnancy of male patients with severe aplastic anemia and Chronic myelogenous leukemia using spermatozoa banked prior to bone marrow transplantation...
Schools
Washington University St Louis
Jewish HospWash University
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Clinical Cardiac Electrophysiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
Washington University - Barnes-Jewish Hospital -
Barnes-Jewish Hospital -
Washington University School of Medicine in St. Louis
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1750326716 | |
| NPPES Provider LastName | CHUNG | |
| NPPES Provider FirstName | MINA | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Cardiac Electrophysiology | |
| Total Claim Count | 1063.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1750326716 |
| Last Name Of The Provider | CHUNG |
| First Name Of The Provider | MINA |
| View All |
Similar Doctors
|
|
Dr. Vijaiganesh Nagarajan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wael A. Jaber, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Bruce D. Lindsay, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Bruce S. Stambler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Heather L. Gornik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ohad Ziv, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter Zimbwa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Grace Cater, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maan Fares, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David S. Lee, MD |
|
|
Dr. Prashanth S. Katrapati, MD |
|
|
Dr. Roopinder K. Sandhu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Victoria Zysek, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patricia A. Gum, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nikhil C. Panda, MD |
|
|
Dr. Mohammed A. Chamsi-Pasha, MD |
|
|
Dr. Maria M. Patarroyo, MD |
|
|
Dr. Andres P. Schuster, MD |